MedPath

The clinical application of thunder-fire moxibustion to breast cancer chemotherapy-induced nausea and vomiting

Phase 1
Recruiting
Conditions
bresst cancer
Registration Number
ITMCTR2100004292
Lead Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Patients are informed, agree and sign the Informed Consent, voluntarily participate in this observation study, comply with the researcher's needs, promise to accept the treatment and safety observation, and facilitate follow-up.
(2) For females, the youngest is 18 years old and the oldest is 75 years old.
(3) Breast cancer diagnosed after pathological examination.
(4) Patients who have completed at least 3 chemotherapy cycles.
(5) Pre-chemotherapy evaluation card score is greater than or equal to 60.
(6) Breast cancer patients who received EC (cyclophosphamide + epirubicin) hyperemetic chemotherapy.
(7) Blood images, liver and kidney functions before chemotherapy were in the normal range, meeting the basic indications and requirements of chemotherapy.
(8) Lucid, no serious hearing impairment, a certain degree of comprehension and language skills.

Exclusion Criteria

(1) Language barrier preventing sufficient communication ability.
(2) Nausea or vomiting within 24 hours before chemotherapy.
(3) Patients with severe or uncontrolled organic lesions or infections, such as decompensated heart, liver, lung, or renal failure.
(4) Persons suffering from uncontrollable mental illness or mental disorder
(5) Patients with obstruction of the digestive tract.
(6) Metastasized breast cancer.
(7) Pregnant and lactating women.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
KPS score;grade of nausea, vomiting and appetite;TCM clinical syndrome score;
Secondary Outcome Measures
NameTimeMethod
CINV risk assessment for breast cancer;life function index scale;
© Copyright 2025. All Rights Reserved by MedPath